Literature DB >> 24323058

Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population.

Pradeep Tyagi1, Vikas Tyagi, Xianggui Qu, Hsin-Tzu Lin, Hann-Chorng Kuo, Yao-Chi Chuang, Michael Chancellor.   

Abstract

INTRODUCTION: Although epidemiology studies consistently report increased prevalence of overactive bladder (OAB) with age, an accurate deciphering of causative links between the two entities remains elusive. Studies on aged rodent bladder have so far yielded contradictory results on age-associated changes in muscarinic receptors, which highlight the challenge posed by species differences in understanding OAB pathology. We hypothesized that age-related biochemical changes in bladder leading to altered bladder function will be reflected in altered urinary proteome of elderly OAB patients.
METHODS: Single time point urine specimens were obtained from 140 OAB patients in the age range of 25-90 years of either sex coming routinely to the urology clinics. Eight chemokines in urine were measured by MILLIPLEX MAP human cytokine/chemokine multiplex immunoassay and ELISA. Multivariate and univariate statistical analyses were done to determine association of age with urinary chemokines in OAB patients.
RESULTS: In agreement with age-dependent higher prevalence of OAB, the logistic regression of the data also revealed the significant association of OAB symptoms with age [odds ratio (OR) 1.12; 95 % CI, (1.072, 1.187), p = 0.0001]. Univariate analysis of 8 urinary proteins revealed an age-associated elevation of NGF (nerve growth factor) in 137 out of 140 OAB patients [Pearson r = 0.274; 95 %CI (0.112-0.422); p = 0.001]. Modest correlation with age was also noted for MCP-1 (monocyte chemoattractant protein-1), which was detected in 115 OAB patients, and the remaining chemokines were undetectable in nearly two-third of OAB patients included in our cohort.
CONCLUSIONS: Based on our findings, we postulate that age-associated biochemical changes may accentuate the inflammation associated with OAB. Urinary NGF elevation in elderly OAB patients may be a homeostatic response to counter the senescence of bladder nerves and arrest the progression of OAB into detrusor hyperactivity with impaired contractility. Likewise, elevation of MCP-1 may be related to decreased muscle mass and increased content of adipose tissue in bladder of elderly OAB patients. Urinary NGF and MCP-1 can serve as surrogate markers for monitoring age-associated biochemical changes and the effect of therapeutic interventions in OAB patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323058     DOI: 10.1007/s11255-013-0621-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

Review 1.  Major urologic problems in geriatrics: assessment and management.

Authors:  Thomas J Guzzo; George W Drach
Journal:  Med Clin North Am       Date:  2011-01       Impact factor: 5.456

2.  Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA).

Authors:  M L A S Santos; W F Gomes; D S Pereira; D M G Oliveira; J M D Dias; E Ferrioli; L S M Pereira
Journal:  Arch Gerontol Geriatr       Date:  2011 May-Jun       Impact factor: 3.250

3.  Impaired bladder function in aging male rats.

Authors:  Weixin Zhao; Tamer Aboushwareb; Chanda Turner; Cathy Mathis; Colleen Bennett; William E Sonntag; Karl-Erik Andersson; George Christ
Journal:  J Urol       Date:  2010-05-20       Impact factor: 7.450

4.  Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.

Authors:  Naoki Yoshimura; Nelson E Bennett; Yukio Hayashi; Teruyuki Ogawa; Osamu Nishizawa; Michael B Chancellor; William C de Groat; Satoshi Seki
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

5.  Chemokine response to febrile urinary tract infection.

Authors:  Gisela Otto; Marie Burdick; Robert Strieter; Gabriela Godaly
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

6.  Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder.

Authors:  M K Pagala; L Tetsoti; D Nagpal; G J Wise
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

Review 7.  Perspectives on overactive bladder in the elderly population.

Authors:  Masaki Yoshida
Journal:  World J Urol       Date:  2009-11-11       Impact factor: 4.226

Review 8.  Neurotrophins as regulators of urinary bladder function.

Authors:  Peter Ochodnicky; Célia D Cruz; Naoki Yoshimura; Francisco Cruz
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

9.  Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.

Authors:  Hsin-Tzu Liu; Michael B Chancellor; Hann-Chorng Kuo
Journal:  BJU Int       Date:  2009-02-11       Impact factor: 5.588

10.  Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.

Authors:  Hann-Chorng Kuo; Hsin-Tzu Liu; Michael B Chancellor
Journal:  Neurourol Urodyn       Date:  2010-03       Impact factor: 2.696

View more
  13 in total

1.  Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients.

Authors:  S Ida; R Kaneko; H Nagata; Y Noguchi; Y Araki; M Nakai; S Ito; K Imataka; K Murata
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Overactive Bladder Is Strongly Associated With Frailty in Older Individuals.

Authors:  Anne M Suskind; Kathryn Quanstrom; Shoujun Zhao; Mark Bridge; Louise C Walter; John Neuhaus; Emily Finlayson
Journal:  Urology       Date:  2017-05-11       Impact factor: 2.649

3.  Methodology for a vaginal and urinary microbiome study in women with mixed urinary incontinence.

Authors:  Yuko M Komesu; Holly E Richter; Darrell L Dinwiddie; Nazema Y Siddiqui; Vivian W Sung; Emily S Lukacz; Beri Ridgeway; Lily A Arya; Halina M Zyczynski; Rebecca G Rogers; Marie Gantz
Journal:  Int Urogynecol J       Date:  2016-10-13       Impact factor: 2.894

4.  The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder.

Authors:  Anne M Suskind
Journal:  Curr Bladder Dysfunct Rep       Date:  2017-02-06

5.  Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Curr Urol       Date:  2016-09-20

Review 6.  Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System.

Authors:  Mahendra Pratap Kashyap; Callie Roberts; Mohammad Waseem; Pradeep Tyagi
Journal:  Mol Neurobiol       Date:  2018-01-25       Impact factor: 5.590

7.  Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.

Authors:  Edmond Changkyun Park; Jae Sung Lim; Seung Il Kim; Sang-Yeop Lee; Yu-Kyung Tak; Chi-Won Choi; Sungho Yun; Joohyun Park; Minji Lee; Hyo Kyun Chung; Koon Soon Kim; Yong Gil Na; Ju Hyun Shin; Gun-Hwa Kim
Journal:  Mol Cell Proteomics       Date:  2018-02-01       Impact factor: 5.911

Review 8.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

9.  Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital.

Authors:  Oktay Üçer; Ömer Demir; Mehmet Fatih Zeren; Yasin Ceylan; İlker Çelen; Ali Ersin Zümrütbaş; Gökhan Temeltaş; Ozan Bozkurt; Bülent Günlüsoy; Orçun Çelik; Gökhan Ekin; Oğuz Mertoğlu
Journal:  Int Neurourol J       Date:  2016-03-07       Impact factor: 2.835

10.  Aging and serum MCP-1 are associated with gut microbiome composition in a murine model.

Authors:  Melissa N Conley; Carmen P Wong; Kyle M Duyck; Norman Hord; Emily Ho; Thomas J Sharpton
Journal:  PeerJ       Date:  2016-03-31       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.